TL;DR
Get beauty and skincare favorites delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
The Week 42 review recorded major ownership moves, sales updates and retail expansion across global beauty, including Galderma’s agreed $1.5 billion acquisition of ZO Skin Health and EU approval of Kimberly-Clark’s Kenvue deal after a divestment agreement. The report also cited investment in manufacturing and sustainability, while legal disputes, trade delays and regulatory scrutiny added pressure. Several reported developments lack detailed terms or outcomes in the source summary.
Global Cosmetics News’ Week 42 review brought together developments in acquisitions, sales, retail expansion and manufacturing investment across the cosmetics and personal care industry. Among the reported moves, Galderma agreed to acquire ZO Skin Health for $1.5 billion, while the European Union approved Kimberly-Clark’s proposed $40 billion acquisition of Kenvue following a divestment agreement. The roundup also highlighted legal disputes, trade delays and calls for tighter consumer-protection rules.
The review described a week of portfolio changes and deal activity. Galderma’s agreement to buy ZO Skin Health would expand its physician-dispensed skincare portfolio. Separately, Bogart sold its 47-store Israeli cosmetics retail subsidiary for €5.8 million. The EU’s approval of Kimberly-Clark’s Kenvue acquisition followed an agreement to divest assets, although the summary did not identify the assets or provide the transaction’s expected closing date. Outside beauty, Amazon was reported to be in discussions to acquire AI start-up Decart for about $7 billion.
On trading and performance, LVMH reported higher third-quarter sales across its beauty operations and Sephora network. Shein reported a 26% rise in UK sales to £2.58 billion, surpassing Asos, according to the review. e.l.f. Beauty said it planned to put a $50 million tariff refund toward pricing and marketing. The report also said Beauty Tech Group executives sold £6 million in shares after the company’s strong initial public offering performance; it did not give further detail on the timing or sellers.
Retail expansion extended across Asia and India. CJ Olive Young increased K-beauty distribution through Sephora stores in Southeast Asia and Hong Kong, while Nykaa and L’Oréal backed a new Kiehl’s skincare launch in India. Kiko Milano said it planned to double its Indian retail footprint by the end of 2026. In the United States, Bluemercury relaunched its Lune+Aster makeup brand with a refreshed identity and wider assortment. Other developments included e.l.f. Cosmetics’ virtual experience on ZEPETO and Bandai’s expansion of Tamagotchi cosmetics licensing in Asian markets.
Deals and Expansion Reshape Beauty
The reported developments show beauty companies pursuing several strategies at once: buying brands, broadening distribution and investing in production and marketing. The Galderma-ZO Skin Health agreement would add to Galderma’s physician-dispensed skincare offer, while the Kenvue transaction’s EU approval marks a regulatory milestone for a large cross-sector deal. Retail plans in India and Sephora’s expanded K-beauty distribution could also affect how brands reach consumers in fast-growing markets.
But expansion is not the only pressure shaping the sector. The Shiseido-Shein dispute over alleged unauthorised cosmetics sales, customs delays affecting French exporters in China and calls for stronger UK aesthetics rules point to legal, trade and consumer-protection risks. These issues can affect product access, brand rights and operating costs, though the roundup does not quantify their financial impact.
Investment extends beyond storefronts. Estée Lauder committed €5.7 million to advanced manufacturing capabilities at its Belgian facility, and L’Oréal Travel Retail partnered with Avolta on sustainability initiatives in duty-free beauty. The report described the areas of activity but did not provide performance targets or measured results.
As an affiliate, we earn on qualifying purchases.
A Week Across Beauty Markets
The review spans global beauty groups, specialist retailers, technology companies and adjacent businesses. Its items range from corporate deals and quarterly sales to new retail locations, digital marketing experiments and executive changes. That breadth matters when reading the roundup: some entries describe completed steps, such as a subsidiary sale or regulatory approval, while others are plans, discussions or reported initiatives whose outcomes remain pending.
Several entries also involve claims or proposals rather than settled findings. Shiseido’s case concerns alleged unauthorised sales, and the AI-generated Hunter and Rhode Beauty concept was described as raising questions about unofficial collaborations and marketing use of generative technology. Superdrug called for stronger regulation of the UK aesthetics industry; the review did not report a new law or regulatory decision. Kering and LVMH, meanwhile, strengthened their model protection charter with updated industry standards.
As an affiliate, we earn on qualifying purchases.
Deal Terms and Disputes Remain Open
The source roundup does not provide full transaction documents, closing schedules or detailed terms for the Galderma-ZO Skin Health agreement or the Kimberly-Clark-Kenvue deal. It also does not specify the assets covered by the divestment agreement that preceded EU approval. Amazon’s reported talks to acquire Decart were discussions, not a confirmed completed acquisition.
Outcomes of the Shiseido lawsuit and the China customs delays were not given. The report does not detail the allegations, Shiseido’s requested remedies, the scope or duration of the delays, or their effects on exporters. It also leaves unclear what will happen to Isamaya Ffrench’s namesake brand after her departure, and whether the reported retail and sustainability plans will meet stated timelines or produce measurable results.
As an affiliate, we earn on qualifying purchases.
Closings, Rollouts and Rulings
Attention will turn to whether the agreed and approved transactions proceed to completion, and whether the companies disclose more detail on timing and terms. Kiko Milano’s stated goal is to double its Indian retail footprint by the end of 2026; the review gives no store count or interim milestones. Retailers and brands may also provide further information as their distribution, product launches and digital experiences roll out.
Legal proceedings and trade conditions will shape the next updates on the Shiseido-Shein dispute and French exporters’ customs delays in China. The industry will also be watching for any policy response to Superdrug’s call for stronger aesthetics regulation. The review does not identify scheduled rulings, government decisions or other fixed dates, so those developments remain open.
As an affiliate, we earn on qualifying purchases.
Key Questions
What were the main developments in the Week 42 review?
The roundup covered acquisitions and disposals, sales updates, international retail expansion, manufacturing and sustainability investment, digital initiatives, legal disputes and regulatory concerns. Galderma’s agreed $1.5 billion purchase of ZO Skin Health and EU approval of Kimberly-Clark’s Kenvue deal were among the major corporate developments.
Did Galderma complete its acquisition of ZO Skin Health?
The review says Galderma agreed to acquire ZO Skin Health for $1.5 billion. It does not say the deal had closed or provide a closing date.
What did the review say about beauty retail expansion?
CJ Olive Young expanded K-beauty distribution through Sephora stores in Southeast Asia and Hong Kong. Kiko Milano outlined a plan to double its Indian retail footprint by the end of 2026, while Bluemercury relaunched its Lune+Aster makeup brand in the United States.
What legal and trade issues were reported?
Shiseido filed a €2.6 million lawsuit against Shein over alleged unauthorised cosmetics sales. The review also said French cosmetics exporters faced customs delays in China amid trade tensions. It provided no case outcome or detailed estimate of the delays’ effects.
What remains uncertain after the roundup?
Key open points include the closing dates and detailed terms of major deals, the outcome of the Shiseido lawsuit, the duration and impact of customs delays, and the future of Isamaya Ffrench’s namesake brand following her departure. The review did not provide measured results for the cited sustainability initiatives.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
